Biotech Values

[investorgold2002]

"The emphasis in an argument for inequitable conduct will have to be on the materiality of the information in question."


Don't you think the fact that they did not adequately discuss 2 clinical studies where they concluded Copolymer of 11K-23K DA mol weight is safe during the prosecution of patent, is MATERIAL ENOUGH for patentability of this patent which claims "Copolymer of 5-9KDA mol weight is less toxic"